Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Change in Receivables (2016 - 2025)

CNBX Pharmaceuticals (CNBX) has disclosed Change in Receivables for 6 consecutive years, with $133.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables changed N/A year-over-year to $133.0, compared with a TTM value of -$3161.0 through Nov 2025, down 91.23%, and an annual FY2025 reading of -$1641.0, up 98.17% over the prior year.
  • Change in Receivables was $133.0 for Q4 2025 at CNBX Pharmaceuticals, up from -$1641.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $133.0 in Q4 2025 and bottomed at -$1653.0 in Q3 2024.